Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06162468Not ApplicableNot Yet Recruiting

Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts

Role: collaborator

NCT06854120Not Yet Recruiting

Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects

Role: collaborator

NCT01486680Not ApplicableCompleted

Silastic Ring Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Obese Patients

Role: lead

NCT01252420Phase 4Unknown

Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis

Role: collaborator

All 4 trials loaded